Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · IEX Real-Time Price · USD
4.360
+0.260 (6.34%)
Mar 28, 2024, 12:27 PM EDT - Market open

Aquestive Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Revenue
50.5847.6850.8345.8552.6167.4366.9251.79
Revenue Growth (YoY)
6.09%-6.20%10.87%-12.85%-21.98%0.77%29.22%-
Cost of Revenue
20.8319.3914.9912.9620.3620.9919.8216.38
Gross Profit
29.7528.2935.8432.8932.2546.4447.135.41
Selling, General & Admin
31.7552.8853.4855.8964.3472.2725.0820.8
Research & Development
13.117.4817.0519.8920.5723.1122.1315.45
Other Operating Expenses
00000000.1
Operating Expenses
44.8570.3670.5275.7884.9295.3847.2136.35
Operating Income
-15.1-42.07-34.68-42.89-52.67-48.94-0.11-0.95
Interest Expense / Income
7.4612.4422.4613.029.327.717.716.14
Other Expense / Income
-14.94-0.113.4-0.134.264.731.122.51
Pretax Income
-7.63-54.41-70.54-55.78-66.25-61.38-8.94-9.6
Income Tax
0.250000000
Net Income
-7.87-54.41-70.54-55.78-66.25-61.38-8.94-9.6
Preferred Dividends
0000002.482.34
Net Income Common
-7.87-54.41-70.54-55.78-66.25-61.38-11.42-11.94
Shares Outstanding (Basic)
614938342521121119
Shares Outstanding (Diluted)
614938342521121119
Shares Change
25.69%27.99%13.15%32.71%22.34%-82.90%2.06%-
EPS (Basic)
-0.13-1.12-1.85-1.66-2.61-2.96-0.09-0.10
EPS (Diluted)
-0.13-1.12-1.85-1.66-2.61-2.96-0.09-0.10
Free Cash Flow
-7.38-10.84-33.89-45.98-60.87-14.823.76-9.15
Free Cash Flow Per Share
-0.12-0.22-0.89-1.37-2.40-0.710.03-0.08
Gross Margin
58.82%59.34%70.51%71.72%61.30%68.87%70.38%68.37%
Operating Margin
-29.86%-88.23%-68.22%-93.55%-100.11%-72.58%-0.17%-1.83%
Profit Margin
-15.56%-114.11%-138.77%-121.67%-125.92%-91.02%-17.07%-23.06%
Free Cash Flow Margin
-14.58%-22.74%-66.67%-100.28%-115.71%-21.97%5.61%-17.67%
EBITDA
1.18-39.58-45.11-39.32-54.02-50.432.570.43
EBITDA Margin
2.34%-83.01%-88.75%-85.76%-102.69%-74.79%3.83%0.83%
Depreciation & Amortization
1.352.392.963.442.913.243.83.89
EBIT
-0.16-41.97-48.08-42.76-56.93-53.67-1.24-3.46
EBIT Margin
-0.32%-88.02%-94.58%-93.26%-108.21%-79.59%-1.85%-6.68%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).